COMMUNIQUÉS West-GlobeNewswire

Fractyl Health to Report Third Quarter 2026 Financial Results and Provide Business Updates on November 12, 2026
06/11/2026
BURLINGTON, Mass., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company or Fractyl), a clinical-stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity [...]
Satellos Changes Primary Efficacy Endpoint in BASECAMP Phase 2 Pediatric Trial to MRI-Measured Fat Fraction Following FDA Feedback
06/11/2026
Fat fraction, together with clinical endpoints, may support a potential accelerated approval pathway for forazapadin Protocol amendment submitted to implement the new primary efficacy endpoint Topline 12-week placebo- [...]
What Do Healthcare Sharing Programs Actually Cover, and What They Don’t
06/11/2026
Eligibility guidelines are where healthcare sharing programs differ most, especially for pre-existing conditions, routine care, mental health, maternity, and prescriptions. WeShare Health begins sharing pre-existing [...]
Treace Announces First Surgical Cases with the Tailorplasty™ MIS Tailor’s Bunion Correction System
06/11/2026
New solution for 5ᵗʰ metatarsal deformities further broadens portfolio and provides access to incremental surgical procedures PONTE VEDRA, Fla., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” [...]
Anika Reports Third Quarter 2026 Financial Results
06/11/2026
Revenue Increased 10% Year Over Year, Led by 17% Commercial Channel Growth Including More Than 30% Growth in Integrity TM Revenue Secured New 10-Year Hyvisc® Partnership with Enhanced Economics; Reintroduced Hyaff Non- [...]
Treace Medical Concepts Reports Third Quarter 2026 Financial Results
06/11/2026
Achieved double digit procedure volume growth in the third quarter PONTE VEDRA, Fla., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology [...]
Arch Biopartners Arranges Non-Brokered Private Placement
06/11/2026
TORONTO, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Arch Biopartners Inc . (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that it has arranged a non-brokered private placement offering of 1,058, [...]
Can-Fite to Pursue Global Licensing and Strategic Partnerships at BIO-Europe 2026 Following Recent Clinical and Intellectual Property Milestones
06/11/2026
Company to leverage positive Phase IIa pancreatic cancer results presented at ESMO 2026, two pivotal Phase III programs, and expanding patent protection to advance global partnering opportunities RAMAT GAN, Israel, Nov [...]
Davion Healthcare Plc Appoints Vienna Capital Partners to Support US$100 Million Acquisition Financing Strategy
06/11/2026
Financial advisory appointment to support planned acquisitions of profitable, revenue-generating businesses during 2027 DUBLIN, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Davion Healthcare Plc (NASDAQ: DAVI) (“Davion” or the “ [...]
InflaRx Announces Publication of Phase 1 Data Demonstrating Favorable Safety and Pharmacokinetic/Pharmacodynamic Profile of Izicopan
06/11/2026
Izicopan achieved rapid and sustained inhibition of C5a/C5aR1 signaling Pharmacokinetic results demonstrated dose-dependent exposure, with izicopan well tolerated across all single and multiple doses evaluated Findings [...]
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/11/2026
SAN DIEGO, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a biopharmaceutical company focused on precision medicines for the treatment of cancer, today announced that on November 2 [...]
Notice of Annual General Meeting 2026
06/11/2026
The Annual General Meeting of Coloplast A/S will be held on Tuesday, 1 December 2026 at 3:30 pm CET at the premises of Coloplast A/S, Holtedam 3 (the Aage Louis-Hansen Auditorium), Humlebæk, Denmark. The notice of the [...]
Regenerative Ophthalmology Takes Center Stage This November 7 at the Next Generation Medicine Congress 2026 in Dubai
06/11/2026
DUBAI, United Arab Emirates, Nov. 06, 2026 (GLOBE NEWSWIRE) -- As the globe moves to the era of cellular restoration in healthcare, Next Generation Medicine Congress 2026 decided to dedicate November 7–10, 2026, to four [...]
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
06/11/2026
RADNOR, Pa., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in [...]
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2026 Financial Results
06/11/2026
SOUTH SAN FRANCISCO, Calif., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class [...]
Once-Weekly TransCon® CNP (Navepegritide) to Receive 10 Years of Market Exclusivity Upon Approval in the European Union
06/11/2026
– Final European Commission decision expected during Q4 2026 COPENHAGEN, Denmark, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the Committee for Orphan Medicinal Products ( [...]
Curonix Freedom® Peripheral Nerve Stimulator (PNS) System Named Top New Pain Management Technology in Orthopedics This Week's Inaugural 2026 Awards
06/11/2026
POMPANO BEACH, Fla., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Curonix, a leading medical technology company dedicated to relieving chronic pain, today announced that the Freedom® Peripheral Nerve Stimulator (PNS) System has [...]
Protara Therapeutics Announces Third Quarter 2026 Financial Results and Provides a Business Update
06/11/2026
Expect to complete enrollment of the BCG-Unresponsive registrational cohort of the ADVANCED-2 trial of TARA-002 in NMIBC by year-end 2026 Enrollment in registrational STARBORN-1 trial now expected to complete in early [...]
Integra LifeSciences to Present at the 2026 UBS Global Healthcare Conference
06/11/2026
PRINCETON, N.J., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Lea Knight, chief financial officer, will [...]

Pages